Inter-chain disulfide bond improved protein trans-splicing increases plasma coagulation activity in C57BL/6 mice following portal vein FVIII gene delivery by dual vectors

Science China Life Sciences

Volumn 56, Issue 3, 2013, Pages 262-267

  Zhu, FuXiang ^a   Liu, ZeLong ^a   Wang, XiaoLei ^b   Miao, Jing ^a   Qu, HuiGe ^a   Chi, XiaoYan ^a  

^a LUDONG UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

coagulation factor VIII; dual vector gene delivery; plasma coagulation activity; protein trans splicing

Indexed keywords

MUS;

EID: 84875385209     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-013-4455-7     Document Type: Article

References (21)

1. Zhu F X, Liu Z L, Chi X Y, et al. Protein trans-splicing based dual-vector delivery of the coagulation factor VIII gene. Sci China Life Sci, 2010, 53: 683-689.
2. Wu H, Xu M Q, Liu X Q. Protein trans-splicing and functional mini-inteins of a cyanobacterial dnaB intein. Biochim Biophys Acta, 1998, 1387: 422-432.
3. Scallan C D, Liu T, Parker A E, et al. Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII. Blood, 2003, 102: 3919-3926.
4. Zhang K, Shen X, Wu J, et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell, 2006, 124: 587-599.
5. Zhu F X, Liu Z L, Miao J, et al. Cys mutation of Met662 and Asp1828 strengthens splicing of coexpressed B-domain-deleted FVIII heavy and light chains by intein. Chin J Biochem Mol Biol, 2012, 28: 234-239.
6. Burton M, Nakai H, Colosi P, et al. Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein. Proc Natl Acad Sci USA, 1999, 96: 12725-12730.
7. Chen L X, Zhu F X, Li J, et al. The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol Ther, 2007, 15: 1856-1862.
8. Swaroop M, Moussalli M, Pipe S W, et al. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII. J Biol Chem, 1997, 272: 24121-24124.
9. Arruda V R, Stedman H H, Haurigot V, et al. Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B. Blood, 2010, 115: 4678-4688.
10. Niemeyer G P, Herzog R W, Mount J, et al. Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. Blood, 2009, 113: 797-806.
11. Sarkar R, Mucci M, Addya S, et al. Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice. Hum Gene Ther, 2006, 17: 427-439.
12. Kaufman R J, Wasley L C, Dorner A J. Synthesis, processing, and secretion of recombinant human factor VI11 expressed in mammalian cell. J Biol Chem, 1988, 263: 6352-6362.
13. Sabatino D S, Lange A M, Altynova E S, et al. Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectors. Mol Ther, 2011, 19: 442-449.
14. Mah C, Sarkar R, Zolotukhin I, et al. Dual vectors expressing murine factor VIII result in sustained correction of hemophilia A mice. Hum Gene Ther, 2003, 14: 143-152.
15. Pipe S W. Coagulation factors with improved properties for hemophilia gene therapy. Semin Thromb Hemost, 2004, 30: 227-237.
16. Miao H Z, Sirachainan N, Palmer L, et al. Bioengineering of coagulation factor VIII for improved secretion. Blood, 2004, 103: 3412-3419.
17. Gale A J, Radtke K P, Cunningham M A, et al. Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants. J Thromb Haemost, 2006, 4: 1315-1322.
18. Zhu F X, Liu Z L, Miao J, et al. Enhanced plasma factor VIII activity via Cys mutation in mice using dual vectors. Sci China Life Sci, 2012, 55: 521-526.
19. Zhu F X, Yang S D, Liu Z L, et al. The effect of a secretion-enhanced heavy chain on improving intein-based dual-vector co-delivery of a full-length factor VIII gene. Chin Sci Bull, 2011, 56: 158-163.
20. Kaufman R J. Genetic engineering of factor VIII. Nature, 1989, 342: 207-208.
21. Vila-Perello M, Muir T W. Biological applications of protein splicing. Cell, 2010, 143: 191-200.